[1] |
Galli SJ, Tsai M, Piliponsky AM.The development of allergic inflammation[J]. Nature, 2008, 454(7203): 445-454.
|
[2] |
Jutel M, Akdis CA.Immunological mechanism of allergenspecifie immunotherapy[J]. Allergy, 2011, 66(6): 725-732.
|
[3] |
Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy[J]. J Allergy Clin Immunol, 2015, 136(3): 556-568.
|
[4] |
Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum[J]. Respirology, 2006, 11(1): 54-61.
|
[5] |
Chai Q, Li CP.Allergen-specific immunotherapeutic effect of recombinant Blo t 21 T protein on asthma in a mouse model[J]. Chin J Parasitol Parasit Dis, 2019, 37(3): 286-290. (in Chinese)(柴强, 李朝品. 重组蛋白Blo t 21 T特异性免疫治疗哮喘小鼠效果研究[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(3): 286-290.)
|
[6] |
Zhu HB, Duan BB, Xu HF, et al. Construction and identification of a recombinant proteins with T-cell epitopes of major allergen group 1 from Dermatophagoides farana[J]. Chin J Microecol, 2015, 27(7): 766-769. (in Chinese)(祝海滨, 段彬彬, 徐海丰, 等. 粉尘螨1类变应原T细胞表位重组蛋白的构建及鉴定[J]. 中国微生态学杂志, 2015, 27(7): 766-769.)
|
[7] |
Zhao BB, Jiang YX, Diao JD, et al. Construction of a vector encoding T-cell epitopes of Dermatophagoides pteronyssinus major allergen group 1 as a vaccine delivered by MHC class Ⅱ pathway[J]. J South Med Univ, 2015, 35(2): 174-178. (in Chinese)(赵蓓蓓, 姜玉新, 刁吉东, 等. 经MHCⅡ通路的屋尘螨1类变应原T细胞表位融合肽疫苗载体的构建与表达[J]. 南方医科大学学报, 2015, 35(2): 174-178.)
|
[8] |
Zhan XD, Duan BB, Hong Y, et al. A specific immune therapeutic effect of Der p2 T cell epitope vaccine on asthma mice[J]. Chin J Schisto Control, 2017, 29(1): 59-63. (in Chinese)(湛孝东, 段彬彬, 洪勇, 等. 屋尘螨变应原Der p2 T细胞表位疫苗对哮喘小鼠的特异性免疫治疗效果[J]. 中国血吸虫病防治杂志, 2017, 29(1): 59-63.)
|
[9] |
Wu QZ, Tang Y, Hu XY, et al. Regulation of Th1/Th2 balance through OX40/OX40L signalling by glycyrrhizic acid in a murine model of asthma[J]. Respirology, 2016, 21(1): 102-111.
|
[10] |
Shi YH, Shi GC, Wan HY, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma[J]. Chin Med J, 2011, 124(13): 1951-1956.
|
[11] |
Kim Y, Lee S, Kim YS, et al. Regulation of Th1/Th2 cells in asthma development: a mathematical model[J]. Math Biosci Eng, 2013, 10(4): 1095-1133.
|
[12] |
Liu ZW, Shen WH.Clinical study of TH17 cells in patients with allergic asthma[J]. Int J Lab Med, 2016, 37(7): 995-997. (in Chinese)(刘子雯, 申卫红. Th17细胞在过敏性哮喘患者中的临床研究[J]. 国际检验医学杂志, 2016, 37(7): 995-997.)
|
[13] |
Hoe E, Anderson J, Nathanielsz J, et al. The contrasting roles of Th17 immunity in human health and disease[J]. Microbiol Immunol, 2017, 61(2): 49-56.
|
[14] |
Cheung PF, Wong CK, Lam CW.Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation[J]. J Immunol, 2008, 180(8): 5625-5635.
|
[15] |
Fickenscher H, Hör S, Küpers H, et al. The interleukin-10 family of cytokines[J]. Trends Immunol, 2002, 23(2): 89-96.
|